Article Information
History
- September 30, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- William G. Dunn, MBChB*,1,2,3,
- Isabella Withnell, MSc*,4,
- Muxin Gu, PhD1,2,
- Pedro Quiros, PhD5,
- Sruthi Cheloor Kovilakam, PhD1,2,
- Ludovica Marando, MD6,
- Sean Wen, DPhil7,
- Margarete A Fabre, MBChB2,3,7,
- Irina Mohorianu, PhD†,1,
- Dragana Vuckovic, PhD†,8 and
- George S. Vassiliou, MBBS†,1,2,3,*
- 1Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK
- 2Department of Haematology, University of Cambridge, Cambridge, UK
- 3Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK
- 4Division of Biosciences, University College London, London, UK
- 5Department of Biochemistry and Molecular Biology, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, 33006, Oviedo, Spain
- 6Department of Hematology, Mayo Clinic, Rochester, MI, USA
- 7Centre for Genomics Research, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 8Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, UK
- ↵# Corresponding author; email: gsv20{at}cam.ac.uk
↵*† Contributed equally
Posted September 30, 2024.
Machine learning framework for predicting the presence of high-risk clonal haematopoiesis using complete blood count data: a population-based study of 431,531 UK Biobank participants
